A detailed history of Pdt Partners, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 11,701 shares of AXSM stock, worth $1.06 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
11,701
Holding current value
$1.06 Million
% of portfolio
0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.93 - $95.84 $923,559 - $1.12 Million
11,701 New
11,701 $1.05 Million
Q3 2022

Nov 14, 2022

SELL
$36.06 - $69.85 $2.14 Million - $4.14 Million
-59,270 Reduced 87.59%
8,397 $375,000
Q2 2022

Aug 15, 2022

BUY
$21.74 - $46.75 $1.47 Million - $3.16 Million
67,667 New
67,667 $2.59 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.